Evidence map›Paper›PMID 38991711›Full record

ArticleThe European respiratory journal2024

Deep phenotyping of unaffected carriers of pathogenic

Eszter N Tóth, Lucas R Celant, Marili Niglas, Samara Jansen, Jelco Tramper, Nicoleta Baxan, Ali Ashek, Jeroen N Wessels, J Tim Marcus, Lilian J Meijboom and 10 more

Abstract read
In one paragraph

Article in The European respiratory journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Exercise-Induced Pulmonary Hypertension: What Is New?Journal of cardiovascular development and disease · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Eszter N TóthAmsterdam UMC location Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam, The Netherlands.ORCID https://orcid.org/0009-0004-3259-9916
Lucas R CelantAmsterdam UMC location Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0001-6727-7539
Marili NiglasImperial College London, National Heart and Lung Institute, London, UK.ORCID https://orcid.org/0009-0003-6905-5368
Samara JansenAmsterdam UMC location Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam, The Netherlands.
Jelco TramperAmsterdam UMC location Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam, The Netherlands.
Nicoleta BaxanImperial College London, National Heart and Lung Institute, London, UK.
Ali AshekImperial College London, National Heart and Lung Institute, London, UK.
Jeroen N WesselsAmsterdam UMC location Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0003-2401-7707
J Tim MarcusAmsterdam Cardiovascular Sciences, Pulmonary Hypertension and Thrombosis, Amsterdam, The Netherlands.
Lilian J MeijboomAmsterdam Cardiovascular Sciences, Pulmonary Hypertension and Thrombosis, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-7528-8307
Arjan C HouwelingAmsterdam UMC location AMC, Department of Human Genetics, Amsterdam, The Netherlands.
Esther J NossentAmsterdam UMC location Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0003-3854-4137
Jurjan AmanAmsterdam UMC location Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0001-6211-1791
Julien GrynblatINSERM UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", Marie Lannelongue Hospital and Bicêtre Hospital, Le Plessis-Robinson, France.ORCID https://orcid.org/0000-0001-5593-3383
Frédéric PerrosCarMeN Laboratory, INSERM U1060, INRAE U1397, Université Claude Bernard Lyon 1, Pierre-Bénite, France.
David MontaniINSERM UMR_S 999 "Pulmonary Hypertension: Pathophysiology and Novel Therapies", Marie Lannelongue Hospital and Bicêtre Hospital, Le Plessis-Robinson, France.ORCID https://orcid.org/0000-0002-9358-6922
Anton Vonk NoordegraafAmsterdam UMC location Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam, The Netherlands.ORCID https://orcid.org/0000-0002-4057-758X
Lan ZhaoImperial College London, National Heart and Lung Institute, London, UK.ORCID https://orcid.org/0000-0003-1177-5568
Frances S de ManAmsterdam Cardiovascular Sciences, Pulmonary Hypertension and Thrombosis, Amsterdam, The Netherlands.
Harm Jan BogaardAmsterdam UMC location Vrije Universiteit Amsterdam, Department of Pulmonary Medicine, Amsterdam, The Netherlands hj.bogaard@amsterdamumc.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPathogenic variants in the gene encoding for

methods28 unaffected carriers (44±16 years, 57% female) and 21 healthy controls (44±18 years, 48% female) underwent annual screening, including cardiac magnetic resonance imaging, transthoracic echocardiography, cardiopulmonary exercise testing and right heart catheterisation. Right ventricular pressure-volume loops were constructed to assess load-independent contractility and compared with a healthy control group. A transgenic

resultsUnaffected carriers had lower indexed right ventricular end-diastolic (79.5±17.6 mL·m

conclusionUnaffected

Indexed as

Bone Morphogenetic Protein Receptors, Type IIEchocardiographyHypertension, PulmonaryAdultAnimalsCardiac CatheterizationCase-Control StudiesDisease Models, AnimalExercise TestFemaleGenetic Predisposition to DiseaseHeterozygoteHumansMagnetic Resonance ImagingMaleMiddle AgedBMPR2 protein, humanBone Morphogenetic Protein Receptors, Type II

Identifiers

PMID38991711
PMCPMC11447285

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.